November 04, 2016

Today's Top Alzheimer's News


November 3, 2016 Press Release: Former U.S. Surgeon General Dr. David Satcher was officially announced as a new member of the UsAgainstAlzheimer’s (UsA2) Board of Directors, where he will add his voice and influence to a movement calling for urgency and action to defeat a disease that is the third leading cause of death In the United States.

Please join us at 1pm ET on November 15th for an important 1-hour webinar session for all 43 Advisory Council Member Organizations of the AD-PCPRN, as well as PCORI representatives. We will be discussing our new Clinical Trial Recruitment Tools, launched at Connected Partners Conference in Boston on October 20th. To register, please click here


A November 3, 2016 article reported that “U.S. Senator Debbie Stabenow (D-MI) announced Thursday that for the first time Medicare will pay for new individual care plans to support Alzheimer’s patients and their families.”

A November 4, 2016 Nature World News article reported that “A team from Merck Research Laboratories has reported the results of early human and animal trials of a drug called verubecestat.” According to the article, “The team is hopeful it could one day be a therapeutic treatment for the  neurocognitive disorder.”

A November 3, 2016 article reported that “Researchers have new evidence that inflammation plays a key role in concussions, and what they've uncovered will undoubtedly transform the way the medical profession deals with head trauma.”